The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Compliance with Results Reporting at ClinicalTrials.gov
Open accessAbstract
BACKGROUND: The Food and Drug Administration Amendments Act (FDAAA) mandates timely reporting of results of applicable clinical trials to ClinicalTrials.gov. We characterized the proportion of applicable clinical trials with publicly available results and determined independent factors associated with the reporting of results. METHODS: Using an algorithm based on input from the National Library of Medicine, we identified trials that were likely to be subject to FDAAA provisions (highly likely applicable clinical trials, or HLACTs) from 2008 through 2013. We determined the proportion of HLACTs that reported results within the 12-month interval mandated by the FDAAA or at any time during the 5-year study period. We used regression models to examine characteristics associated with reporting at 12 months and throughout the 5-year study period. RESULTS: From all the trials at ClinicalTrials.gov, we identified 13,327 HLACTs that were terminated or completed from January 1, 2008, through August 31, 2012. Of these trials, 77.4% were classified as drug trials. A total of 36.9% of the trials were phase 2 studies, and 23.4% were phase 3 studies; 65.6% were funded by industry. Only 13.4% of trials reported summary results within 12 months after trial completion, whereas 38.3% reported results at any time up to September 27, 2013. Timely reporting was independently associated with factors such as FDA oversight, a later trial phase, and industry funding. A sample review suggested that 45% of industry-funded trials were not required to report results, as compared with 6% of trials funded by the National Institutes of Health (NIH) and 9% of trials that were funded by other government or academic institutions. CONCLUSIONS: Despite ethical and legal obligations to disclose findings promptly, most HLACTs did not report results to ClinicalTrials.gov in a timely fashion during the study period. Industry-funded trials adhered to legal obligations more often than did trials funded by the NIH or other government or academic institutions. (Funded by the Clinical Trials Transformation Initiative and the NIH.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This data may not have been published in any other location, making study registries a critical component of an information strategy, though timely reporting remains a challenge [58, 59].”
From PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews (2021) · cites this paper as [58]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This data may not have been published in any other location, making study registries a critical component of an information strategy, though timely reporting remains a challenge [58, 59].”
From PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews (2021) · cites this paper as [58]
The cited source says what the claim attributes to it.
In the citing paper
“This data may not have been published in any other location, making study registries a critical component of an information strategy, though timely reporting remains a challenge [58, 59].”
From PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews (2021) · cites this paper as [58]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
Nissen, S. E., & Wolski, K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072761 · Cited by 4,675
What Makes Clinical Research Ethical?
Emanuel, E. J. (2000) · JAMA · doi:10.1001/jama.283.20.2701 · Cited by 2,710
Selective publication of antidepressant trials and its influence on apparent efficacy
Turner, E. H., Matthews, A. M., Linardatos, E., Tell, R. A., & Rosenthal, R. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa065779 · Cited by 2,435
The ClinicalTrials.gov Results Database — Update and Key Issues
Zarin, D. A., Tse, T., Williams, R. J., Califf, R. M., & Ide, N. C. (2011) · New England Journal of Medicine · doi:10.1056/nejmsa1012065 · Cited by 838
Self-citationCharacteristics of Clinical Trials Registered in ClinicalTrials.gov, 2007-2010
Califf, R. M. (2012) · JAMA · doi:10.1001/jama.2012.3424 · Cited by 516
Self-citationClinical Trial Registration — Looking Back and Moving Ahead
Laine, C. M., Horton, R. C., DeAngelis, C. D., Drazen, J. M., Frizelle, F., Godlee, F., Haug, C. J., Hébert, P. C., Kotzin, S., Marušić, A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejme078110 · Cited by 320
Prayle, A., Hurley, M. N., & Smyth, A. R. (2012) · BMJ · doi:10.1136/bmj.d7373 · Cited by 299
Disclosing Individual Results of Clinical Research: Implications of Respect for Participants
Shalowitz, D. I., & Miller, F. G. (2005) · JAMA · doi:10.1001/jama.294.6.737 · Cited by 265
Tasneem, A., Aberle, L. H., Ananth, H., Chakraborty, S., Chiswell, K., McCourt, B. J., & Pietrobon, R. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033677 · Cited by 176
Self-citationLaine, C. M., Horton, R. C., DeAngelis, C. D., Drazen, J. M., Frizelle, F., Godlee, F., Haug, C. J., Hébert, P. C., Kotzin, S., Marušić, A., et al. (2007) · JAMA · doi:10.1001/jama.298.1.jed70037 · Cited by 135
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 381
Wang, Q., Huo, X., Cui, J., Li, J., Bai, X., Wu, C., Zhang, Q., Sun, D., & Zhao, J. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-01637-8 · Cited by 7
Timing, modifications, and tenor of firms' mandatory R&D disclosures: The role of competition
Rathee, C., Malik, S., & Salandra, R. (2024) · Research Policy · doi:10.1016/j.respol.2024.105112 · Cited by 9
Dechartres, A., Bond, E. G., Scheer, J., Riveros, C., Atal, I., & Ravaud, P. (2016) · BMC Medicine · doi:10.1186/s12916-016-0740-1 · Cited by 7
A New Approach to Data Sharing and Distributed Ledger Technology: A Clinical Trial Use Case
Ferraiolo, D. F., DeFranco, J. F., Kuhn, D. R., & Roberts, J. D. (2021) · IEEE Network · doi:10.1109/mnet.2021.9355049 · Cited by 6
Smith, E. J., Naik, A., Goel, M., Wen, P. Y., Lim, M. K., Chang, S. M., & Germano, I. M. (2024) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdad169 · Cited by 6
Academic clinical research: Death by a thousand clicks
Stein, C. M. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aab3490 · Cited by 6
Strech, D., & Littmann, J. (2016) · Research Ethics · doi:10.1177/1747016115626497 · Cited by 6
Lammers, A. J., Wang, R., Cetnar, J. P., & Prasad, V. K. (2017) · Blood Cancer Journal · doi:10.1038/s41408-017-0008-9 · Cited by 6
Using previous trial results to inform hypothesis testing of new interventions
Shen, C., & Li, X. (2017) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2017.1402782 · Cited by 5
Underregistration and Underreporting of Stem Cell Clinical Trials in Neurological Disorders
Lee, T. E., Kim, A., Jang, M., & Jeon, B. (2018) · Journal of Clinical Neurology · doi:10.3988/jcn.2018.14.2.215 · Cited by 6
Davidović, N., Tokalić, R., Burilović, E., Pejdo, S., Marušić, A., Singh, S. P., & Franić, T. (2019) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-019-01392-8 · Cited by 6
A Narrative Review of Methods for Causal Inference and Associated Educational Resources
Landsittel, D. P., Srivastava, A., & Kropf, K. (2020) · Quality Management in Health Care · doi:10.1097/qmh.0000000000000276 · Cited by 6
Implementation of 21st Century Cures Act Expanded Access Policies Requirements
Kang, S., Chang, S., Ross, J. S., & Miller, J. E. (2021) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2401 · Cited by 6
Evolving a national clinical trials learning health system
Stensland, K. D., Richesson, R., Vince, R., Skolarus, T. A., & Sales, A. E. (2022) · Learning Health Systems · doi:10.1002/lrh2.10327 · Cited by 5
Inadequate reporting quality of registered genome editing trials: an observational study
Jurić, D., Zlatin, M., & Marušić, A. (2022) · BMC Medical Research Methodology · doi:10.1186/s12874-022-01574-0 · Cited by 6
Mayer, M. G. (2015) · F1000Research · doi:10.12688/f1000research.7037.1 · Cited by 5
The finer points of writing and refereeing scientific articles
Bain, B. J., Littlewood, T. J., & Szydlo, R. (2016) · British Journal of Haematology · doi:10.1111/bjh.13888 · Cited by 5
A transparent future for clinical trial reporting
Karassa, F. B., & Ioannidis, J. P. A. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.65 · Cited by 5
Precision Medicine and Challenges in Research and Clinical Implementation
Haga, S. B. (2017) · Principles of Gender-Specific Medicine · doi:10.1016/b978-0-12-803506-1.00021-8 · Cited by 5
Resultados negativos na pesquisa científica: aspectos éticos
Guimarães, R. A. B., Succi, G. D. M., Montalli, V. Â. M., Niederauer, A. J. S., & Succi, R. C. D. M. (2018) · Revista Bioética · doi:10.1590/1983-80422018262245 · Cited by 8
Abebe, K. Z., Althouse, A. D., COMER, D. M., Holleran, K., Koerbel, G. L., Kojtek, J., Weiss, J., & Spillane, S. (2019) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2019.100488 · Cited by 5
DeVito, N., Drysdale, H., McKee, M., & Goldacre, B. M. (2021) · Tobacco Control · doi:10.1136/tobaccocontrol-2020-056221 · Cited by 6
Reporting bias in completed epilepsy intervention trials: A cross-sectional analysis
Rayi, A., Thompson, S., Gloss, D. S., & Malhotra, K. (2018) · Epilepsy Research · doi:10.1016/j.eplepsyres.2018.03.022 · Cited by 5
Cooper, C. M., Gray, H. M., Barcenas, L., Torgerson, T., Checketts, J. X., & Vassar, M. B. (2020) · Journal of Osteopathic Medicine · doi:10.7556/jaoa.2020.148 · Cited by 5
Strech, D., Sievers, S., Märschenz, S., Riedel, N., Wieschowski, S., Meerpohl, J. J., Langhof, H., Müller-Ohlraun, S., & Dirnagl, U. (2018) · F1000Research · doi:10.12688/f1000research.17022.1 · Cited by 4
Roberts, J. (2016) · Headache The Journal of Head and Face Pain · doi:10.1111/head.12752 · Cited by 5
Concealing research outcomes: Missing data, negative results and missed publications
Bhaskar, S. (2017) · Indian Journal of Anaesthesia · doi:10.4103/ija.ija_361_17 · Cited by 5
Benchmarking transformer embedding models for biomedical terminology standardization
Lahiri, A., Shukla, S., Stear, B. J., Ahooyi, T. M., Beigel, K., Margolskee, E. M., & Taylor, D. M. (2025) · Machine Learning with Applications · doi:10.1016/j.mlwa.2025.100683 · Cited by 9
The Culture of Trial Results Reporting at Academic Medical Centers
Zarin, D. A. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.4200 · Cited by 5
Patry, C., Fichtner, A., Höcker, B., Ries, M., Schmitt, C. P., & Tönshoff, B. (2022) · Pediatric Nephrology · doi:10.1007/s00467-022-05553-x · Cited by 4
Current State of Clinical Trials Regarding Alveolar Bone Grafting
Malak, A. A., Masri, Y. E., Ziab, M. A., Ghazi, M., & Salameh, P. (2023) · The Cleft Palate-Craniofacial Journal · doi:10.1177/10556656231215164 · Cited by 4
Mayer, M. G. (2015) · F1000Research · doi:10.12688/f1000research.6878.1 · Cited by 4
Control of false positives in randomized phase III clinical trials
Shen, C., Liu, Z., Xu, H., Liu, H., & Yue, C. (2016) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2016.1222536 · Cited by 4
Agha, R., Jafree, D. J., Vella‐Baldacchino, M., Limb, C., Kusu‐Orkar, T., Millip, M. C., & Fowler, A. J. (2017) · International Journal of Surgery · doi:10.1016/j.ijsu.2016.12.040 · Cited by 4
Fowler, A. J., Dowlut, N., Limb, R., Vella‐Baldacchino, M., Sonagara, V. J., George, N., Thavayogan, R., Gundogan, B., Limb, C., Jafree, D. J., et al. (2018) · International Journal of Surgery · doi:10.1016/j.ijsu.2018.10.036 · Cited by 4
Deane, B. R., & Sivarajah, J. (2016) · Current Medical Research and Opinion · doi:10.1080/03007995.2016.1263612 · Cited by 4
Warner, F. M., Bailey, N. G. N., Scheuren, P. S., Lütolf, R., McGregor, R., Banga, R., Hsieh, J., & Kramer, J. L. K. (2021) · Spinal Cord · doi:10.1038/s41393-021-00699-1 · Cited by 4
Comparative Assessment of Completeness of CDISC Controlled Terminology
Elghafari, A., & Finkelstein, J. (2022) · Studies in health technology and informatics · doi:10.3233/shti220042 · Cited by 4
Patry, C., Kranig, S. A., Rafat, N., Schaible, T., Toenshoff, B., Hoffmann, G. F., & Ries, M. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-023524 · Cited by 5
Dunn, A. G., Orenstein, L., Coiera, E. W., Mandl, K. D., & Bourgeois, F. T. (2019) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2019.01.009 · Cited by 4
P-hacking in clinical trials and how incentives shape the distribution of results across phases
Adda, J., Decker, C., & Ottaviani, M. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1919906117 · Cited by 57
Negative Is Positive: A Plea to Publish All Studies Regardless of Outcome
Tripathy, D. (2015) · American Journal of Hematology / Oncology® · Cited by 4
Campa, M., Ryan, C., & Menter, A. (2016) · British Journal of Dermatology · doi:10.1111/bjd.14402 · Cited by 4
Factors associated with reporting results for pulmonary clinical trials in ClinicalTrials.gov
Riley, I. L., Boulware, L. E., Sun, J., Chiswell, K., Que, L. G., Kraft, M., Todd, J. L., Palmer, S. M., & Anderson, M. L. (2017) · Clinical Trials · doi:10.1177/1740774517740352 · Cited by 4
Self-citationWang, L., Rouse, B., Marks‐Anglin, A., Duan, R., Shi, Q., Quach, K., Chen, Y., Cameron, C., Schmid, C. H., & Li, T. (2019) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2019.06.010 · Cited by 4
Bourveau, T., Čapkun, V., & Wang, Y. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3533305 · Cited by 4
Gamertsfelder, E., Delgado-Figueroa, N., Keestra, S., Silva, A. R., Borana, R., Siebert, M., & Brückner, T. (2023) · BMJ Evidence-Based Medicine · doi:10.1136/bmjebm-2023-112395 · Cited by 3
Regulatory transparency: social, technical, and ethical aspects of clinical trial data access.
Sousa, V. D., & Silveira, D. (2015) · PubMed · Cited by 3
Quality evaluation of investigator‐initiated trials using post‐approval cancer drugs in Japan
Kondo, S., Hosoi, H., Itahashi, K., & Hashimoto, J. (2017) · Cancer Science · doi:10.1111/cas.13223 · Cited by 3
Clinical Research Informatics: Supporting the Research Study Lifecycle
Johnson, S. B. (2017) · Yearbook of Medical Informatics · doi:10.1055/s-0037-1606503 · Cited by 3
Randomized Phase III Oncology Trials: A Survey and Empirical Bayes Inference
Shen, C., & Xu, H. (2019) · Journal of Statistical Theory and Practice · doi:10.1007/s42519-019-0049-4 · Cited by 2
Publication and associated factors of clinical trials registered in Peru
Heredia, P., Alarcon-Ruiz, C. A., Roque‐Roque, J. S., Cruz-Vargas, J. A. D. L., & Quispe, A. M. (2020) · Journal of Evidence-Based Medicine · doi:10.1111/jebm.12413 · Cited by 3
Could Blockchain Help With COVID-19 Crisis?
Kassab, M., Neto, V. V. G., Destefanis, G., & Malas, T. (2021) · IT Professional · doi:10.1109/mitp.2021.3072585 · Cited by 3
[Challenges of Investigator-initiated Clinical Trials to Support the New Drug Development].
Bai, H., & Zhang, S. (2022) · PubMed Central · doi:10.3779/j.issn.1009-3419.2022.102.31 · Cited by 3
Ye, Q.-M., Chen, Z.-G., Chen, L.-L., Situ, B., Mai, Y.-Y., Xiao, J.-Y., & Yang, Y. (2022) · Journal of Thoracic Disease · doi:10.21037/jtd-22-975 · Cited by 2
Long, Y., Hu, T., Yang, Z., Liqin, L., Lin, Y., Huang, J., & Du, L. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-067379 · Cited by 3
Poor Result Reporting Rate in Cell Therapy Trials Registered at ClinicalTrials.gov
Negoro, T., Okura, H., Hayashi, S., Arai, T., & Matsuyama, A. (2023) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2023.0053 · Cited by 4
Cwajna, M., Hamouda, A. M., Kendall, N. A. S., Ghozy, S. A., Elder, B. D., & Kallmes, D. F. (2024) · Translational Stroke Research · doi:10.1007/s12975-024-01260-x · Cited by 3
Rivero‐de‐Aguilar, A., Pérez‐Ríos, M., Mascareñas‐García, M., Ruano‐Raviña, A., Ross, J. S., Acción, B. C., & Varela‐Lema, L. (2024) · Multiple Sclerosis Journal · doi:10.1177/13524585241273089 · Cited by 3
Chapman, S. J., Shelton, B., Maruthappu, M., Singh, P., McCulloch, P. G., & Bhangu, A. A. (2017) · British journal of surgery · doi:10.1002/bjs.10485 · Cited by 3
Eckert, J. C. (2019) · Medical Care · doi:10.1097/mlr.0000000000001254 · Cited by 3
The Enduring Vitality of Implausible Claims for Neurostimulation and Psychosurgical Therapies
Coffey, R. (2015) · Stereotactic and Functional Neurosurgery · doi:10.1159/000437390 · Cited by 4
Sobczyk, M. K., Zheng, J., Smith, G. D., & Gaunt, T. R. (2022) · medRxiv · doi:10.1101/2022.04.11.22273633 · Cited by 3
Preregistration and Credibility of Clinical Trials *Preprint
Decker, C., & Ottaviani, M. (2023) · medRxiv · doi:10.1101/2023.05.22.23290326 · Cited by 4
The status of clinical trials regarding root canal sealers
Malak, A. A., Masri, Y. E., Ziab, M. A., Zrara, N., Baroud, T., & Salameh, P. (2024) · Restorative Dentistry & Endodontics · doi:10.5395/rde.2024.49.e5 · Cited by 2
Nebeská, K., Součková, L., Štěpánová, R., & Demlová, R. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1590125 · Cited by 2
Racial and ethnic diversity in clinical studies reported to ClinicalTrials.gov, 2009–2024
Aziz, M., O'Brien, E. C., Lusk, J. B., Krishnamurthy, S., Garcha, V., Brookhart, M. A., Califf, R. M., & Green, M. D. (2026) · BMJ Open Quality · doi:10.1136/bmjoq-2025-003801 · Cited by 2
Self-citationA large-scale database for clinical trial outcomes and features
Gao, C., Pradeepkumar, J., Das, T., Thati, S., & Sun, J. (2026) · Nature Health · doi:10.1038/s44360-026-00081-6 · Cited by 18
Who will implement WHO's statement on public disclosure of trial results?
Baylis, F. E., & Herder, M. (2015) · The Lancet · doi:10.1016/s0140-6736(15)61100-x · Cited by 2
Quality and Reporting Accuracy of Phase 1 Drug Radiation Clinical Trials
Kim, H., Dan, T., Palmer, J. D., Leiby, B. E., Lawrence, Y. R., & Dicker, A. P. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.4833 · Cited by 2
Quinn, A. (2016) · De Ethica A Journal of Philosophical Theological and Applied Ethics · doi:10.3384/de-ethica.2001-8819.16325 · Cited by 2
Prospective adverse event risk evaluation in clinical trials
Kundu, A., Feijoo, F., Martínez, D. A., Hermosilla, M., & Matis, T. I. (2021) · Health Care Management Science · doi:10.1007/s10729-021-09584-y · Cited by 2
Interpretable Clinical Trial Search using Pubmed Citation Network
Roy, S., Ganguly, N., Sural, S., & Rudra, K. (2023) · IEEE International Conference on Digital Health (ICDH) · doi:10.1109/icdh60066.2023.00056 · Cited by 2
Postmarket Surveillance of Neuroendovascular Devices
Luff, M. K., Sedrakyan, A., Ansari, S. A., Siddiqui, A. H., & Liebeskind, D. S. (2024) · Stroke Vascular and Interventional Neurology · doi:10.1161/svin.123.001081 · Cited by 2
Hughes, E. A. G., Bakel, T. V., Raudanskis, A., Ray, P., Hodzic-Santor, B. H., Purohit, U., Sacks, C. A., & Fralick, M. (2024) · The Journal of Law Medicine & Ethics · doi:10.1017/jme.2024.135 · Cited by 2
A critique of the moral economy of pharmaceutical development
Kimmelman, J. (2025) · Critical Policy Studies · doi:10.1080/19460171.2025.2457529 · Cited by 2
Cwajna, M., Hamouda, A. M., Kendall, N. A. S., Ghozy, S. A., Atieh, F., Aboseif, A., Ahmed, N. S., Kallmes, D. F., Arumaithurai, K., Abboud, H., et al. (2025) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2025.123744 · Cited by 2
Trust and transparency in clinical trials of medical devices
Kramer, D. B., & Cutlip, D. E. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.112 · Cited by 2
Withycombe, B. M., Ovenell, M., Meeker, A. S., Ahmed, S. M., & Hartung, D. M. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2016.04.007 · Cited by 2
Bridging the Academia/Industry Chasm: Proposed Solutions
Beninger, P. R., Boumil, M. M., Salem, D. N., Getz, K. A., Klapholz, H., Curfman, G., Jotwani, R., & Berman, H. A. (2016) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.762 · Cited by 2
Shamliyan, T., Sundarrajan, R., Camper, D., Middleton, M., & Kadambalithaya, A. P. (2016) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2016.11.005 · Cited by 2
Industry - from sponsor to provider?
Griebenow, R. (2017) · Journal of European CME · doi:10.1080/21614083.2017.1395672 · Cited by 2
Langford, A. T., Sherman, S., Thornton, R. J., Nightingale, K. J., Kwon, S. C., Chavis‐Keeling, D., Link, N., Cronstein, B. N., Hochman, J. S., & Trachtman, H. (2020) · JMIR Public Health and Surveillance · doi:10.2196/12813 · Cited by 2
Barriers to reproducibility: misalignment of career incentives and open science best practices
Mills‐Finnerty, C. (2020) · Journal for Reproducibility in Neuroscience · doi:10.31885/jrn.1.2020.304 · Cited by 2
Publication rate and research topics of studies in pediatric kidney transplantation
Patry, C., Cordts, S., Baumann, L., Höcker, B., Fichtner, A., Ries, M., & Tönshoff, B. (2022) · Pediatric Transplantation · doi:10.1111/petr.14262 · Cited by 3
Characteristics of clinical trials associated with early results reporting at ClinicalTrials.gov
Bashir, R., & Dunn, A. G. (2022) · Contemporary Clinical Trials · doi:10.1016/j.cct.2022.106785 · Cited by 2
A Distributed Ledger Technology Design using Hyperledger Fabric and a Clinical Trial Use Case
Kuhn, D. R., Roberts, J. D., Ferraiolo, D. F., & DeFranco, J. F. (2022) · IEEE Annual Software Technology Conference (STC) · doi:10.1109/stc55697.2022.00031 · Cited by 2
A Cross-Sectional Analysis of Registered Studies on the Promising Dipeptide Carnosine
Pfeffer, T., Wen, D., Stefanidis, K., Peters, V., & Ries, M. (2023) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-023-10553-y · Cited by 2
Research integrity and the law that never was
Mayer, M. G. (2018) · BMJ Evidence-Based Medicine · doi:10.1136/bmjebm-2018-110993 · Cited by 2
Regulatory Approval and Biotechnology Product Disclosures.Preprint
Enache, L., Li, L., & Riedl, E. J. (2018) · SSRN Electronic Journal · doi:10.2139/ssrn.3290822 · Cited by 2
Learning to Share: Lessons on Data-Sharing from Beyond Social MediaPreprint
Nicholas, G., & Thakur, D. (2022) · doi:10.31219/osf.io/2qnhv · Cited by 2
Bariani, B., Pinto, B. S., Santos, L. A., Benatti, R. G., Lessa, M. P. M., Loureiro, J. C., Silva, J. F., Silva, V. A., Cardeal, H. B., Pereira, J. L., et al. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.120182 · Cited by 1
Reporting and enrollment disparities in hematologic malignancy trials between 2000–2023
Gong, I. Y., Rafinejad‐Farahani, B., Majeed, H., Soto, M. J., Oza, A. M., Ehrlich, T., Lynch, H. F., Guerra, C. E., Lofters, A., Unger, J. M., et al. (2025) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2025.2579735 · Cited by 1
Research waste in total knee arthroplasty studies: an observational study on registered trials
Iken, A. R., Schaap, M., Poolman, R. W., & Gademan, M. G. J. (2026) · BMJ Open · doi:10.1136/bmjopen-2024-092409 · Cited by 1
Valiengo, L. D. C. L., Pinto, B. S., Luethi, M. S., Santos, L. A., Benatti, R. G., Lessa, M. P. M., Loureiro, J. C., Silva, J., Martins, L., Oliveira, P. S., et al. (2026) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20250537 · Cited by 1
Melhorn, P., Dominik, N., Rüsing, L. Z., Cserna, J., Knaus, H. A., Schulenburg, A., Mitterbauer, M., Greinix, H., & Rabitsch, W. (2026) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2026.06.023 · Cited by 1
Closeout of the HALT-PKD trials
Moore, C. G., Spillane, S., Simon, G., Maxwell, B., Rahbari-Oskoui, F. F., Braun, W. E., Chapman, A. B., Schrier, R. W., Torres, V. E., Perrone, R. D., et al. (2015) · Contemporary Clinical Trials · doi:10.1016/j.cct.2015.07.017 · Cited by 1
Morley, G. (2015) · Medical Writing · doi:10.1179/2047480615z.000000000300 · Cited by 1
Veitch, K. (2016) · Medical Writing · Cited by 1
Gross, N. J. (2014) · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · doi:10.15326/jcopdf.2.2.2015.0137 · Cited by 1
Metadata
- Authors
- Anderson, M. L., Chiswell, K., Peterson, E. D., Tasneem, A., Topping, J., & Califf, R. M.
- Affiliations
- Duke University (US)
- Duke Medical Center (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-03-12
- Volume
- 372
- Issue
- 11
- Pages
- 1031-1039
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC4508873
- OpenAlex
- W1963526469
- Cited by
- 380
- References
- 19
- Citations by year
- 2026: 21 · 2025: 14 · 2024: 17 · 2023: 18 · 2022: 36 · 2021: 33 · 2020: 37 · 2019: 28 · 2018: 51 · 2017: 38 · 2016: 50 · 2015: 36
- FWCI
- 68.45
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- public-domain
- Locations
- New England Journal of Medicine (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- DukeSpace (Duke University) (submittedVersion)
- Funders
- National Institutes of Health
- U.S. National Library of Medicine
- Duke Clinical Research Institute
- National Center for Complementary and Integrative Health (U54AT007748)
- Topics
- Health Sciences › Nursing › Issues, ethics and legal aspects › Pharmaceutical industry and healthcare
- Social Sciences › Library and Information Sciences › Academic Publishing and Open Access
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Keywords
- ClinicalTrials.gov, result reporting, clinical trial transparency, regulatory compliance, industry-funded trials, trial phase, FDA oversight, drug trials
- MeSH terms
- Algorithms, Clinical Trials as Topic, Drug Industry, Humans, National Library of Medicine (U.S.), Registries, Research Support as Topic, United States, United States Food and Drug Administration, Proportional Hazards Models, Databases, Factual, Disclosure, Government Regulation, Mandatory Programs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
